Timolol Maleate NDC 50090-3441

NDC codes

FDA NDC Directory

Product NDC (as listed)50090-3441Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50090-3441Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50090-3441-0	50090344100	10 mL in 1 BOTTLE, PLASTIC (50090-3441-0)Marketed from Apr 20, 2018

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Timolol Maleate
Generic name (nonproprietary): timolol maleate
Active ingredients: Timolol maleate — 5 mg/mL
Dosage form: Solution
Route: Ophthalmic
Labeler: A-S Medication Solutions
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 074262
Marketing start: Jan 15, 1996
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 50090-3441_78aae6ba-6716-47f9-994d-901bcdf1696aSPL ID 78aae6ba-6716-47f9-994d-901bcdf1696aSPL set ID 5305a38e-d9c8-4f9e-bf67-b246abc82cb1RxCUI 1992303UNII P8Y54F701R
Pharmacologic class: beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450090344100 followed by a unit qualifier and the quantity

Package 50090-3441-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 20, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Timolol maleate ophthalmic solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 074262

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 074262
Product	Strength	Form · route	Labeler	Product NDC
Timolol Maleate	Timolol maleate 5 mg/mL	SolutionOphthalmic	Sandoz Inc	61314-227